Prothromplex NF 600 I.E.

Prothromplex NF 600 I.E. is a medicine authorised by Swissmedic under authorisation number 41330. The authorisation holder is Takeda Pharma AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 August 1979 and the authorisation is valid without a time limit. ATC code B02BD01 places the medicine in the group Antihemorrhagics.

  • Dispensing category B
  • Authorisation number 41330
  • ATC B02BD01
  • Blood products
Authorisation data
Authorisation number41330
NameProthromplex NF 600 I.E.
Full nameProthromplex NF 600 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holderTakeda Pharma AG
Medicinal product codeBlood products
Dispensing categoryB · Prescription only
ATC codeB02BD01
First authorisation07 August 1979
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
2Prothromplex NF 600 I.E., Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB01 September 1993
3Prothromplex NF 500 I.E., Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB16 January 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
581 Durchstechflasche Pulver und 1 Durchstechflasche Lösungsmittel mit 1 GerätesatzB02BD0106.01.1.B
11 Durchstechflasche Pulver und 1 Durchstechflasche Lösungsmittel und 1 Mix2VialB02BD0106.01.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Prothromplex NF 600 I.E. authorised in Switzerland?

Yes. Prothromplex NF 600 I.E. is authorised by Swissmedic under authorisation number 41330, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Prothromplex NF 600 I.E. have?

Prothromplex NF 600 I.E. is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Prothromplex NF 600 I.E.?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com